Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Journey Medical Corporati...

    NASDAQ: DERM · Real-Time Price · USD
    6.73
    -0.05 (-0.74%)
    At close: Jun 16, 2025, 3:59 PM
    6.74
    0.13%
    After-hours: Jun 16, 2025, 04:06 PM EDT

    Journey Medical Statistics

    Share Statistics

    Journey Medical has 23.26M shares outstanding. The number of shares has increased by 4.38% in one year.

    Shares Outstanding

    n/a
    		 23.26M

    Shares Change (YoY)

    n/a
    		 4.38%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 18.45%

    Shares Floating

    n/a
    		 12.04M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,007

    FTD / Avg. Volume

    n/a
    		 1.02%

    Short Selling Information

    The latest short interest is 393.72K, so 1.69% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 393.72K

    Short % of Shares Out

    n/a
    		 1.69%

    Short % of Float

    n/a
    		 3.31%

    Short Ratio (days to cover)

    n/a
    		 4.08

    Valuation Ratios

    The PE ratio is -5.44 and the forward PE ratio is 7.73. Journey Medical's PEG ratio is -0.02.

    PE Ratio

    n/a
    		 -5.44

    Forward PE

    n/a
    		 7.73

    PS Ratio

    n/a
    		 1.42

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 3.98

    P/FCF Ratio

    n/a
    		 -8.75

    PEG Ratio

    n/a
    		 -0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Journey Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.25.

    Current Ratio

    n/a
    		 1.37

    Quick Ratio

    n/a
    		 0.96

    Debt / Equity

    n/a
    		 1.25

    Debt / EBITDA

    n/a
    		 -2.99

    Debt / FCF

    n/a
    		 -2.75

    Interest Coverage

    n/a
    		 -5.07

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,369,121.95

    Profits Per Employee

    n/a
    		 $-357,853.66

    Employee Count

    n/a
    		 41

    Asset Turnover

    n/a
    		 0.7

    Inventory Turnover

    n/a
    		 1.45

    Taxes

    Income Tax

    n/a
    		 61K

    Effective Tax Rate

    n/a
    		 -0.42%

    Stock Price Statistics

    The stock price has increased by 20.83% in the last 52 weeks. The beta is 0.88, so Journey Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.88

    52-Week Price Change

    n/a
    		 20.83%

    50-Day Moving Average

    n/a
    		 6.98

    200-Day Moving Average

    n/a
    		 5.65

    Relative Strength Index (RSI)

    n/a
    		 43.64

    Average Volume (20 Days)

    n/a
    		 99,187

    Income Statement

    In the last 12 months, Journey Medical had revenue of 56.13M and earned -14.67M in profits. Earnings per share was -0.72.

    Revenue

    n/a
    		 56.13M

    Gross Profit

    n/a
    		 35.26M

    Operating Income

    n/a
    		 -13.68M

    Net Income

    n/a
    		 -14.67M

    EBITDA

    n/a
    		 -8.4M

    EBIT

    n/a
    		 -11.91M

    Earnings Per Share (EPS)

    n/a
    		 -0.72
    Full Income Statement

    Balance Sheet

    The company has 20.3M in cash and 25.08M in debt, giving a net cash position of -4.78M.

    Cash & Cash Equivalents

    n/a
    		 20.3M

    Total Debt

    n/a
    		 25.08M

    Net Cash

    n/a
    		 -4.78M

    Retained Earnings

    n/a
    		 -87.03M

    Total Assets

    n/a
    		 84.96M

    Working Capital

    n/a
    		 13.76M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.13M and capital expenditures 0, giving a free cash flow of -9.13M.

    Operating Cash Flow

    n/a
    		 -9.13M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -9.13M

    FCF Per Share

    n/a
    		 -0.45
    Full Cash Flow Statement

    Margins

    Gross margin is 62.81%, with operating and profit margins of -24.36% and -26.14%.

    Gross Margin

    n/a
    		 62.81%

    Operating Margin

    n/a
    		 -24.36%

    Pretax Margin

    n/a
    		 -26.03%

    Profit Margin

    n/a
    		 -26.14%

    EBITDA Margin

    n/a
    		 -14.96%

    EBIT Margin

    n/a
    		 -24.36%

    FCF Margin

    n/a
    		 -16.26%

    Dividends & Yields

    DERM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for DERM is $10, which is 48.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 48.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.89

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist